SCHEMBL4618904

SCHEMBL4618904

Cc1ccc(S(=O)(=O)c2ccccc2)cc1S(=O)(=O)NCCN1CCOCC1

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.68
MAPK1 P28482 2/20 0.68
SFRP1 Q8N474 2/20 0.61
L3MBTL1 Q9Y468 2/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
HPGD P15428 2/20 0.58
HSD17B10 Q99714 1/20 0.58
CYP3A4 P08684 2/20 0.55
KDM4E B2RXH2 1/20 0.55
MEN1 O00255 1/20 0.55
CYP2C9 P11712 1/20 0.55
KMT2A Q03164 1/20 0.55
TSHR P16473 1/20 0.55
USP2 O75604 1/20 0.54
PKM P14618 2/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C19 P33261 1/20 0.53
POLB P06746 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4638749 0.94 SFRP1 (0.66) ALDH1A1MAPK1SFRP1L3MBTL1SMN1; SMN2
SCHEMBL4618056 0.90 ALDH1A1 (0.67) ALDH1A1MAPK1L3MBTL1SMN1; SMN2HPGD
SCHEMBL4619595 0.90 ALDH1A1 (0.67) ALDH1A1MAPK1L3MBTL1HPGDHSD17B10
SCHEMBL4616478 0.90 SFRP1 (0.66) ALDH1A1MAPK1SFRP1L3MBTL1SMN1; SMN2
SCHEMBL4616479 0.88 SFRP1 (0.74) ALDH1A1MAPK1SFRP1L3MBTL1SMN1; SMN2
SCHEMBL6103833 0.87 KMT2A (0.59) ALDH1A1MAPK1SFRP1L3MBTL1SMN1; SMN2
SCHEMBL4616589 0.86 SMN1; SMN2 (0.69) ALDH1A1MAPK1SFRP1SMN1; SMN2KMT2A
SCHEMBL4618073 0.86 ALDH1A1 (0.62) ALDH1A1MAPK1SFRP1MEN1KMT2A
SCHEMBL4617493 0.84 SFRP1 (0.78) ALDH1A1SFRP1L3MBTL1SMN1; SMN2CYP3A4
SCHEMBL4636995 0.84 CYP3A4 (0.67) ALDH1A1MAPK1SFRP1L3MBTL1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 ALDH1A1 1865/4885MAPK1 934/4885SFRP1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.